Bayer and Harvard Institute Extend Research for Cancer Therapies

Bayer and the Broad Institute of MIT and Harvard have recently confirmed the continuation of their collaborative research work for another five years after a successful decade-long partnership

Lupin Launches Diazepam Rectal Gel in US Markets

The unveiling of diazepam rectal gel, available in doses of 10 mg and 20 mg, has been declared by Lupin Limited

Illumina Unveils Liquid Biopsy Assay For Genomic Profiling

Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, has announced the availability of a new version of their distributed liquid biopsy test for genomic profiling. The TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2)...

SPARC Forms Licensing Agreement With JHU & IOCB for Alopecia Drugs

Sun Pharma Advanced Research Company Ltd. (SPARC) announced an agreement with Johns Hopkins University (JHU) and The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB) (Licensors) to exclusively license SCD-153...

US FDA Nods Keytruda Plus Gemcitabine & Cisplatin To treat patients

Merck (MSD) announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck's anti-PD-1 therapy, in combination with gemcitabine and cisplatin for the treatment of patients with locally advanced unresectable or metastatic...

NRx Pharma Inks Development Agreement To Produce Ketamine

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical firm, has announced the signing of a development contract to produce a Ketamine formulation suited for intravenous administration in accordance with current FDA manufacturing rules...

Karyopharm and Bristol Myers Sign Clinical Trial Collaboration

Karyopharm Therapeutics recently announced that it and Bristol-Myers Squibb have partnered on a clinical trial to assess the efficacy of mezigdomide, a proprietary investigational cereblon E3 ligase modulator (CELMoD) agent, in combination with...

Aragen Invests $30 million For Bio-manufacturing site in Bangalore

Aragen, a leading contract research development and manufacturing organization (CRDMO) for small molecules

IKS Health Purchases AQuity for $200 Million

Mumbai-based healthcare technology provider IKS Health announced on Tuesday that it has acquired AQuity Solutions

GSK Announces Clinical Trial for Endometrial Cancer Chemotherapy

GSK plc announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III

© 2025 India Pharma Outlook. All Rights Reserved.